Mostrar el registro sencillo del ítem

Artículo

dc.creatorFalcón Boyano, Déboraes
dc.creatorGaleano-Otero, Isabeles
dc.creatorCalderón Sánchez, Eva Maríaes
dc.creatorToro Estévez, Raquel deles
dc.creatorMartín Bórnez, Martaes
dc.creatorRosado, Juan Antonioes
dc.creatorHmadcha, Abdelkrimes
dc.creatorSmani Hajami, Tarikes
dc.date.accessioned2019-04-02T09:20:55Z
dc.date.available2019-04-02T09:20:55Z
dc.date.issued2019
dc.identifier.citationFalcón Boyano, D., Galeano-Otero, I., Calderón Sánchez, E.M., Toro Estévez, R.d., Martín Bórnez, M., Rosado, J.A.,...,Smani Hajami, T. (2019). TRP Channels: Current Perspectives in the Adverse Cardiac Remodeling. Frontiers in Physiology, 10 (art.159), 1-12. https://doi.org/10.3389/fphys.2019.00159.
dc.identifier.issn1664-042Xes
dc.identifier.urihttps://hdl.handle.net/11441/85032
dc.description.abstractCalcium is an important second messenger required not only for the excitation-contraction coupling of the heart but also critical for the activation of cell signaling pathways involved in the adverse cardiac remodeling and consequently for the heart failure. Sustained neurohumoral activation, pressure-overload, or myocardial injury can cause pathologic hypertrophic growth of the heart followed by interstitial fibrosis. The consequent heart’s structural and molecular adaptation might elevate the risk of developing heart failure and malignant arrhythmia. Compelling evidences have demonstrated that Ca2+ entry through TRP channels might play pivotal roles in cardiac function and pathology. TRP proteins are classified into six subfamilies: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPML (mucolipin), and TRPP (polycystin), which are activated by numerous physical and/or chemical stimuli. TRP channels participate to the handling of the intracellular Ca2+ concentration in cardiac myocytes and are mediators of different cardiovascular alterations. This review provides an overview of the current knowledge of TRP proteins implication in the pathologic process of some frequent cardiac diseases associated with the adverse cardiac remodeling such as cardiac hypertrophy, fibrosis, and conduction alteration.es
dc.description.sponsorshipSpanish Ministry of Economy and Competitiveness BFU2016–74932-C2es
dc.description.sponsorshipInstitute of Carlos III PI15/00203; PI16/00259; CB16/11/00431es
dc.description.sponsorshipAndalusia Government PI-0313-2016es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherFrontiers Mediaes
dc.relation.ispartofFrontiers in Physiology, 10 (art.159), 1-12.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectcalciumes
dc.subjectTRP channelses
dc.subjectcardiac remodelinges
dc.subjecthypertrophyes
dc.subjectfibrosises
dc.subjectconduction disorderses
dc.titleTRP Channels: Current Perspectives in the Adverse Cardiac Remodelinges
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Fisiología Médica y Biofísicaes
dc.relation.projectIDBFU2016–74932-C2es
dc.relation.projectIDPI15/00203; PI16/00259; CB16/11/00431es
dc.relation.projectIDPI-0313-2016es
dc.relation.publisherversion10.3389/fphys.2019.00159es
dc.identifier.doi10.3389/fphys.2019.00159es
idus.format.extent12 p.es
dc.journaltitleFrontiers in Physiologyes
dc.publication.volumen10es
dc.publication.issueart.159es
dc.publication.initialPage1es
dc.publication.endPage12es
dc.description.awardwinningPremio Mensual Publicación Científica Destacada de la US. Facultad de Medicina

FicherosTamañoFormatoVerDescripción
pubfphys-10-00159.pdf1.167MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional